All About Eye Drops: Warnings To Six Homeopathic And Two Allopathic Firms; Seven US, One Swiss

Common across warnings is all the firms, retailers as well as manufacturers, are marketing OTC eye drops with noncompliant claims, including “prevent or improve cataracts” and “temporarily alleviate blepharitis symptoms.” One also had GMP problems.

• Source: Shutterstock

Eight businesses recently received US Food and Drug Administration warning letters about OTC drugs “especially concerning from a public health perspective.”

Seven of the firms are in the US, one is in Switzerland; six were warned about potential problems with homeopathic...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Compliance

More from Policy & Regulation